These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16670313)

  • 1. Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effects.
    Luo W; Ko E; Hsu JC; Wang X; Ferrone S
    J Immunol; 2006 May; 176(10):6046-54. PubMed ID: 16670313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with a human high molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitro.
    Wagner S; Hafner C; Allwardt D; Jasinska J; Ferrone S; Zielinski CC; Scheiner O; Wiedermann U; Pehamberger H; Breiteneder H
    J Immunol; 2005 Jan; 174(2):976-82. PubMed ID: 15634921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential immunogenicity of two peptides isolated by high molecular weight-melanoma-associated antigen-specific monoclonal antibodies with different affinities.
    Luo W; Hsu JC; Tsao CY; Ko E; Wang X; Ferrone S
    J Immunol; 2005 Jun; 174(11):7104-10. PubMed ID: 15905554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactivity of mimotopes with a monoclonal antibody against the high molecular weight melanoma-associated antigen (HMW-MAA) does not predict cross-reactive immunogenicity.
    Hafner C; Wagner S; Allwardt D; Riemer AB; Scheiner O; Pehamberger H; Breiteneder H
    Melanoma Res; 2005 Apr; 15(2):111-7. PubMed ID: 15846144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of mimotope-induced anti-high molecular weight-melanoma associated antigen (HMW-MAA) antibodies does not ensure biological activity.
    Latzka J; Gaier S; Hofstetter G; Balazs N; Smole U; Ferrone S; Scheiner O; Breiteneder H; Pehamberger H; Wagner S
    PLoS One; 2011 May; 6(5):e19383. PubMed ID: 21573118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells.
    Riemer AB; Hantusch B; Sponer B; Kraml G; Hafner C; Zielinski CC; Scheiner O; Pehamberger H; Jensen-Jarolim E
    Cancer Immunol Immunother; 2005 Jul; 54(7):677-84. PubMed ID: 15565329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiotypic cascade in the human high molecular weight melanoma-associated antigen system: fine specificity and idiotypic profile of anti-anti-idiotypic monoclonal antibodies.
    Yang H; Chen ZJ; Kageshita T; Yamada M; Ferrone S
    Eur J Immunol; 1993 Jul; 23(7):1671-7. PubMed ID: 7686858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human high-molecular-weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody TK7-371.
    Chen ZJ; Yang H; Kageshita T; Ferrone S
    Cancer Res; 1991 Sep; 51(18):4790-7. PubMed ID: 1716513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1.
    Chattopadhyay P; Kaveri SV; Byars N; Starkey J; Ferrone S; Raychaudhuri S
    Cancer Res; 1991 Nov; 51(22):6045-51. PubMed ID: 1933867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2.
    Wang X; Ko EC; Peng L; Gillies SD; Ferrone S
    Cancer Res; 2005 Aug; 65(15):6976-83. PubMed ID: 16061683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation by adjuvants and carriers of the immunogenicity in xenogeneic hosts of mouse anti-idiotypic monoclonal antibody MK2-23, an internal image of human high molecular weight-melanoma associated antigen.
    Chen ZJ; Yang H; Liu CC; Hirai S; Ferrone S
    Cancer Res; 1993 Jan; 53(1):112-9. PubMed ID: 8416734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human high molecular weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody MK2-23. Characterization of the immunogenicity in syngeneic hosts.
    Chen ZJ; Yang H; Ferrone S
    J Immunol; 1991 Aug; 147(3):1082-90. PubMed ID: 1861071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
    Murray JL; Gillogly M; Kawano K; Efferson CL; Lee JE; Ross M; Wang X; Ferrone S; Ioannides CG
    Cancer Res; 2004 Aug; 64(15):5481-8. PubMed ID: 15289358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of melanoma targeting human high molecular weight melanoma-associated antigen: potential role of nonimmunological mechanisms.
    Chang CC; Campoli M; Luo W; Zhao W; Zaenker KS; Ferrone S
    Ann N Y Acad Sci; 2004 Dec; 1028():340-50. PubMed ID: 15650259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.
    Mittelman A; Chen ZJ; Yang H; Wong GY; Ferrone S
    Proc Natl Acad Sci U S A; 1992 Jan; 89(2):466-70. PubMed ID: 1731316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
    Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
    Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
    Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
    Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of human melanoma tumor growth in severe combined immunodeficient mice by passive transfer of antibodies induced by a high molecular weight melanoma-associated antigen mimotope vaccine.
    Wagner S; Krepler C; Allwardt D; Latzka J; Strommer S; Scheiner O; Pehamberger H; Wiedermann U; Hafner C; Breiteneder H
    Clin Cancer Res; 2008 Dec; 14(24):8178-83. PubMed ID: 19088033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
    Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
    Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of syngeneic antiidiotypic monoclonal antibodies to murine anti-human high molecular weight melanoma-associated antigen monoclonal antibodies.
    Kusama M; Kageshita T; Chen ZJ; Ferrone S
    J Immunol; 1989 Dec; 143(11):3844-52. PubMed ID: 2584721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.